Brief Title
A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary
Official Title
Seroprevalence of Bordetella Pertussis in Adults in Hungary
Brief Summary
The purpose of this study is to perform an epidemiological survey of the adult population in Hungary to calculate the seroprevalence of pertussis.
Detailed Description
The protocol posting was amended to correct the detailed title. Since a sample of blood will be collected from all subjects (outside of routine hospital procedure), the study does not meet GSK's definition of an observational study and hence the term "observational" was deleted from the detailed title.
Study Type
Interventional
Primary Outcome
Number of Seropositive Subjects in Terms of Anti-pertussis Toxin (Anti-PT) Concentrations
Secondary Outcome
Number of Seropositive Subjects in Terms of Anti-PT Concentrations (by Age)
Condition
Pertussis
Intervention
Blood sampling
Study Arms / Comparison Groups
Study Group
Description: Subjects, male and female, aged 18 years and above who had agreed to collection of blood sample.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
2000
Start Date
April 24, 2014
Completion Date
April 24, 2015
Primary Completion Date
April 22, 2015
Eligibility Criteria
Inclusion Criteria: - Subjects who the investigator believes can and will comply with the requirements of the protocol. - Written informed consent will be obtained from subjects prior to performing any study procedures. - Males or females ≥ 18 years of age at the time of enrollment. - Agreeing to collection of a blood sample for the study. Exclusion Criteria: • Confirmed or suspected immunological disorder.
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
GSK Clinical Trials, ,
Location Countries
Hungary
Location Countries
Hungary
Administrative Informations
NCT ID
NCT02014519
Organization ID
116804
Responsible Party
Sponsor
Study Sponsor
GlaxoSmithKline
Study Sponsor
GSK Clinical Trials, Study Director, GlaxoSmithKline
Verification Date
November 2019